共 50 条
- [21] Bendamustine rituximab primary therapy for Waldenstrom Macroglobulinemia: an international, multicenter collaborative study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S127 - S128
- [24] Deletions of chromosomes 6Q and 13Q and trisomy 4 are the most common cytogenetic abnormalities in waldenstrom macroglobulinemia. Preliminary results of a multicentric study HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 220 - 220
- [25] Deletions of chromosomes 6Q and 13Q, and trisomy 4 are the most common cytogenetic abnormalities in Waldenstrom macroglobulinemia. Preliminary results of a multicentric study HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 331 - 331